Literature DB >> 30945089

Incidence and prevalence of Parkinson's disease in the Italian region of Umbria: a population-based study using healthcare administrative databases.

Paolo Eusebi1,2, David Franchini3, Marcello De Giorgi3, Iosief Abraha3, Alessandro Montedori3, Paola Casucci3, Paolo Calabresi4,5, Nicola Tambasco4.   

Abstract

Parkinson's disease is known to pose a significant burden on society in industrialized countries. However, few studies have been conducted in Italy using administrative healthcare databases for epidemiological purposes. We wanted to estimate the incidence and prevalence rates of Parkinson's disease in the Italian region of Umbria by means of linkage between several sources of administrative healthcare data: hospitalization episodes, exemptions from medical charges, drug prescriptions from general practitioners and physicians working in the public sector. Using a pre-defined algorithm, we estimated incident and prevalent cases of Parkinson's disease for the year 2016. The regional incidence rate, adjusted with Italian standard population data, was 0.40 new cases/1000 person-years (0.41 in females, 0.39 in males). We estimated that 5550 subjects were affected by Parkinson's disease, leading to an age-adjusted prevalence rate of 5.42/1000 inhabitants. Prevalence and incidence increased with age and male gender. However, due to the longer life expectancy of females, the absolute number of prevalent cases was greater among females. The heterogeneity of spatial distribution of disease was high. A considerable proportion of prevalent cases was hospitalized in 2016. The most recurrent reasons for hospitalization episodes were disorders related to the nervous system, respiratory system, cardiovascular system, and musculoskeletal and connective tissue apparatus. The study findings support the feasibility of future epidemiological studies of Parkinson's disease with administrative data as well as the need for an integrative care pathway for the patients with Parkinson's disease.

Entities:  

Keywords:  Epidemiology; Incidence; Parkinson’s disease; Prevalence

Mesh:

Year:  2019        PMID: 30945089     DOI: 10.1007/s10072-019-03872-w

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

1.  Reduced serum SIRT1 levels in patients with Parkinson's disease: a cross-sectional study in China.

Authors:  Yuting Zhu; Xiangyang Zhu; Yong Zhou; Dongmei Zhang
Journal:  Neurol Sci       Date:  2020-09-09       Impact factor: 3.307

2.  Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson's disease.

Authors:  Xiaoxue Shi; Jinhua Zheng; Jianjun Ma; Zhidong Wang; Wenhua Sun; Mingjian Li; Shen Huang; Shiyu Hu
Journal:  Neurol Sci       Date:  2021-08-18       Impact factor: 3.307

3.  Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Asra Fazlollahi; Mahdi Zahmatyar; Hossein Alizadeh; Maryam Noori; Nasrin Jafari; Seyed Aria Nejadghaderi; Mark J M Sullman; Koroush Gharagozli; Ali-Asghar Kolahi; Saeid Safiri
Journal:  BMC Neurol       Date:  2022-10-11       Impact factor: 2.903

4.  Burden of Parkinson's disease in Sicily: a health administrative database study.

Authors:  Calogero Edoardo Cicero; Salvatore Scondotto; Alessandra Vincenza Allotta; Giovanni De Luca; Giuseppe Murolo; Alessandra Nicoletti; Mario Zappia
Journal:  Neurol Sci       Date:  2021-07-14       Impact factor: 3.307

Review 5.  The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols.

Authors:  Sunisha Aryal; Taylor Skinner; Bronwyn Bridges; John T Weber
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

6.  Prevalence of Parkinson Disease in Italy: a systematic review and meta-analysis.

Authors:  Matteo Riccò; Luigi Vezzosi; Federica Balzarini; Giovanni Gualerzi; Silvia Ranzieri; Carlo Signorelli; Maria Eugenia Colucci; Nicola Luigi Bragazzi
Journal:  Acta Biomed       Date:  2020-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.